Lab21 has announced it has purchased the majority shareholding of Biotec Laboratories, a clinical diagnostic company with particular emphasis on infectious diseases, most notably tuberculosis (TB).
As part of the sale, Lab21 also acquires Biotec's South African subsidiary, Biotec Laboratories SA, which is a joint venture with the Cape Biotech Trust.
Biotec Laboratories, based in Ipswich, UK, was established in 1993 and has developed a portfolio of diagnostic products with a particular focus on infectious diseases.
The two companies have had an ongoing commercial relationship, with Biotec Laboratories distributing some of Lab21's diagnostic products through its global network of distributors in 80 countries.
Biotec Laboratories will continue to trade as a subsidiary of Lab21 group.
